WVP
GRTS

Worth Venture Partners’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Worth Venture Partners’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-43,772
Closed -$75.3K – 176
2023
Q3 		$75.3K Hold
43,772
– – 0.04% 124
2023
Q2 		$85.4K Buy
43,772
+5,393
+14% +$12.6K 0.05% 135
2023
Q1 		$107K Buy
+38,379
New +$110K 0.05% 140

Other funds holding GRTS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Worth Venture Partners's GRTS Position: Q4 2023 in Review

Worth Venture Partners sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2023, closing a stake of 43,772 shares — an estimated $75.3K sold.

Worth Venture Partners first reported a position in GRTS in Q1 2023 and held it in 3 quarters. The position peaked at $107K in Q1 2023. 88 funds tracked by Wall St. Rank hold GRTS as of Q4 2023.

  • Worth Venture Partners reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Worth Venture Partners sold 43,772 Gritstone bio, Inc. Common Stock shares in Q4 2023, an estimated $75.3K.
  • Worth Venture Partners first reported a position in Gritstone bio, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • Worth Venture Partners's Gritstone bio, Inc. Common Stock position peaked at $107K in Q1 2023.
  • 88 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2023.

Based on Worth Venture Partners's 13F filing for Q4 2023, filed 9 Feb 2024.